Scaling Biologics Manufacturing in a Changing World: How Biopharma is Rethinking Launches, Partnerships and Resilience

About this session

The path to commercialization has become increasingly complex. While technical expertise, quality and speed remain essential, biopharma companies are now making manufacturing decisions against a backdrop of geopolitical uncertainty, shifting trade dynamics, regional market requirements and continued pressure on capital efficiency. As a result, the criteria for selecting and managing manufacturing partners are evolving. Companies must balance resilience with flexibility, geographic diversification with operational efficiency, and short-term execution with long-term strategic value.

Speakers

• JS

  Jennifer Smith-Parker

  Director of Insights · BioSpace

  Moderator

• CG

  Cristina Grigore

  Director, Commercial Development, EMEA/APAC · Lonza

  Speaker